GlassScriptPhysician profile
Brady Nicholas Biscorner
NPI 1528638822
$8,699.29
in general payments reported to CMS, 2019-2025
43 companies · $1,440 in 2025
The $1,440 reported for 2025 was more than what 77% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,078 · 2022: $985 · 2023: $1,744 · 2024: $2,452 · 2025: $1,440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,694 · Travel and Lodging: $942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,694.46 |
| Travel and Lodging | $942.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,320.92 | 2021-2024 | Ortholoc 3di, Citrefix, 7 X 23mm Citrelock Implant |
| Liberty Surgical INC. | $1,200.00 | 2021 | |
| Kerecis Limited | $922.58 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Orthofix Medical, INC. | $777.45 | 2024-2025 | Truelok, Physio-Stim |
| Paragon 28, INC. | $642.57 | 2024-2025 | Additive Orthopedics, Phantom Fibula Nail, Phantom Hindfoot |
| Smith+Nephew, INC. | $525.38 | 2021-2025 | Stravix, Stravix Pl, Grafix Pl |
| Paratek Pharmaceuticals, INC. | $349.32 | 2021-2025 | Nuzyra |
| Integra Lifesciences Corporation | $268.75 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $257.24 | 2021-2023 | Strensiq |
| Ibsa Pharma INC. | $229.11 | 2023-2024 | Licart |
| Aroa Biosurgery Incorporated | $191.58 | 2022 | |
| Nevro Corp. | $190.43 | 2023 | Senza |
| Voom Medical Devices, INC. | $164.84 | 2025 | Revcon Instrument Kit, Sterile |
| Bioventus LLC | $134.75 | 2021 | |
| Solventum Corporation | $133.93 | 2024-2025 | Activ.A.C., V.A.C.Ulta, V.A.C. Veraflo |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $123.96 | 2023 | |
| Arthrex, INC. | $122.60 | 2025 | |
| Kci USA, INC. | $104.92 | 2021-2022 | |
| Depuy Synthes Sales INC. | $98.37 | 2022-2025 | Motoband |
| Linvatec Corporation | $98.17 | 2025 | Colink Afx, Biobrace 23mm, Fracture and Correction Colag 2 |
| Forma Medical | $77.37 | 2025 | Optimalmtp |
| Urgo Medical North America, LLC | $71.99 | 2025 | Urgoclean Ag |
| Sanara Medtech INC. | $70.43 | 2024-2025 | Biasurge, Celleraterx |
| Ossur Americas, INC. | $68.84 | 2025 | Unloader One X |
| Ferring Pharmaceuticals INC. | $57.04 | 2024-2025 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $56.70 | 2024-2025 | |
| Treace Medical Concepts, INC. | $53.57 | 2025 | |
| Abbvie INC. | $48.57 | 2023-2024 | Dalvance |
| Dynasplint Systems INC. | $47.25 | 2024 | Dynasplint |
| Musculoskeletal Transplant Foundation INC. | $45.29 | 2023 | |
| Averitas Pharma INC. | $43.20 | 2023 | Qutenza |
| Zimmer Biomet Holdings, INC. | $22.20 | 2021 | |
| Heron Therapeutics, INC. | $19.88 | 2022 | |
| Organogenesis INC. | $19.75 | 2025 | Novachor |
| Eclipse Technology Solutions INC. | $17.64 | 2023 | |
| Nalu Medical, INC. | $16.85 | 2025 | Nalu Neurostimulation System |
| Metric Medical Devices, INC. | $16.66 | 2023 | Super Staple, Super Scaffold |
| Paladin Technology Solutions | $16.28 | 2025 | |
| Advanced Oxygen Therapy INC. | $15.75 | 2025 | Topical Oxygen Chamber For Extremities |
| Nabriva Therapeutics, Plc | $14.96 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $14.67 | 2023 | Crysvita |
| Kowa Pharmaceuticals America, INC. | $14.39 | 2023 | Seglentis |
| Grt US Holding, INC. | $13.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brady Biscorner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.